Encompass Health
EHC
597 hedge funds and large institutions have $9.63B invested in Encompass Health in 2026 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 224 increasing their positions, 223 reducing their positions, and 41 closing their positions.
61% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 41
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
3% more funds holding
Funds holding: 580 → 597 (+17)
3% more capital invested
Capital invested by funds: $9.32B → $9.63B (+$317M)
3% more call options, than puts
Call options by funds: $11.9M | Put options by funds: $11.5M
0% more repeat investments, than reductions
Existing positions increased: 224 | Existing positions reduced: 223
0.46% less ownership
Funds ownership: 96.94% → 96.48% (-0.46%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$212M |
| 2 |
EP
Eversept Partners
New York
|
+$86.2M |
| 3 |
Holocene Advisors
New York
|
+$85.7M |
| 4 |
Jane Street
New York
|
+$59.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$47.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$325M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$230M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$59M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$36M |
| 5 |
Squarepoint
New York
|
-$31.5M |
EHC Hedge Fund Activity: Q2 2026 in Review
597 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q2 2026, worth a combined $9.63B — up 3.4% from $9.32B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new EHC positions and 41 closed out — a net gain of 25 holders — while 224 added to existing stakes and 223 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $212M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $325M.
- 597 institutional investors held Encompass Health (EHC) as of Q2 2026, up from 580 in Q1 2026.
- Funds reported $9.63B of Encompass Health stock for Q2 2026, up 3.4% quarter-over-quarter.
- 66 funds opened new Encompass Health positions in Q2 2026 and 41 closed out, a net change of +25 holders.
- The largest Encompass Health buyer in Q2 2026 was Citadel Advisors, an estimated $212M added.
- The largest Encompass Health seller in Q2 2026 was T. Rowe Price Investment Management, an estimated $325M sold.
Based on aggregated 13F filings for Q2 2026.